- $736.52m
- $1.16bn
- $482.26m
- 53
- 28
- 26
- 28
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 18.09 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.36 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -27.01% | ||
| Return on Equity | -1000.48% | ||
| Operating Margin | -29.95% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 113.43 | 144.86 | 243.21 | 350.87 | 482.26 | 602.1 | 727.39 | 39.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
Directors
- Patrick Miles CHM (55)
- J. Todd Koning CFO (48)
- Craig Hunsaker EVP (57)
- David Sponsel EVP (42)
- Brian Snider EVP (43)
- Eric Dasso EVP (48)
- Kelli Howell EVP (47)
- Mark Ojeda EVP (51)
- Scott Lish SVP (40)
- Mortimer Berkowitz LED (67)
- Jeffrey Rydin DRC (54)
- Beth Altman IND
- Evan Bakst IND (54)
- Quentin Blackford IND (43)
- Jason Hochberg IND (49)
- Karen McGinnis IND (54)
- Marie Meynardier IND
- David Mowry IND (58)
- David Pelizzon IND (65)
- James Tullis IND (73)
- Ward Woods IND (78)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- March 4th, 2005
- Public Since
- June 2nd, 2006
- No. of Shareholders
- 381
- No. of Employees
- 839
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 143,014,000
- Address
- 5818 El Camino Real, CARLSBAD, 92008
- Web
- https://atecspine.com/
- Phone
- +1 null7604319286
- Contact
- Tina Jacobsen
- Auditors
- Deloitte & Touche LLP
Latest News for ATEC
Upcoming Events for ATEC
Q3 2024 Alphatec Holdings Inc Earnings Release
Q3 2024 Alphatec Holdings Inc Earnings Call
Q4 2024 Alphatec Holdings Inc Earnings Release
Similar to ATEC
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Angiodynamics
NASDAQ Global Select Market
FAQ
As of Today at 19:12 UTC, shares in Alphatec Holdings are trading at $5.15. This share price information is delayed by 15 minutes.
Shares in Alphatec Holdings last closed at $5.15 and the price had moved by -53.22% over the past 365 days. In terms of relative price strength the Alphatec Holdings share price has underperformed the S&P500 Index by -65.19% over the past year.
The overall consensus recommendation for Alphatec Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAlphatec Holdings does not currently pay a dividend.
Alphatec Holdings does not currently pay a dividend.
Alphatec Holdings does not currently pay a dividend.
To buy shares in Alphatec Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.15, shares in Alphatec Holdings had a market capitalisation of $736.52m.
Here are the trading details for Alphatec Holdings:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ATEC
Based on an overall assessment of its quality, value and momentum Alphatec Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alphatec Holdings is $17.46. That is 239.03% above the last closing price of $5.15.
Analysts covering Alphatec Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$1.06 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alphatec Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -66.29%.
As of the last closing price of $5.15, shares in Alphatec Holdings were trading -53.66% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alphatec Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Alphatec Holdings' management team is headed by:
- Patrick Miles - CHM
- J. Todd Koning - CFO
- Craig Hunsaker - EVP
- David Sponsel - EVP
- Brian Snider - EVP
- Eric Dasso - EVP
- Kelli Howell - EVP
- Mark Ojeda - EVP
- Scott Lish - SVP
- Mortimer Berkowitz - LED
- Jeffrey Rydin - DRC
- Beth Altman - IND
- Evan Bakst - IND
- Quentin Blackford - IND
- Jason Hochberg - IND
- Karen McGinnis - IND
- Marie Meynardier - IND
- David Mowry - IND
- David Pelizzon - IND
- James Tullis - IND
- Ward Woods - IND